Cited by 237Bone Metabolism and DiseasesProtease and Inhibitor MechanismsRheumatoid Arthritis Research and Therapies

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand.

Open access

Hikita, Atsuhiko, Yana, Ikuo, Wakeyama, Hidetoshi, Nakamura, Masaki, Kadono, Yuho, Oshima, Yasushi, Nakamura, Kozo, Seiki, Motoharu, Tanaka, Sakae·2006·Journal of Biological Chemistry

DOI 10.1074/jbc.m606656200

Open this paper in CoChat — free account

Abstract

Receptor activator of NF-kappaB ligand (RANKL) is a transmembrane glycoprotein that has an essential role in the development of osteoclasts. The extracellular portion of RANKL is cleaved proteolytically to produce soluble RANKL, but definite RANKL sheddase(s) and the physiologic function of RANKL shedding have not yet been determined. In the present study, we found that matrix metalloproteinase (MMP) 14 and a disintegrin and metalloproteinase (ADAM) 10 have strong RANKL shedding activity. In Western blot analysis, soluble RANKL was detected as two different molecular weight products, and RNA interference of MMP14 and ADAM10 resulted in a reduction of both the lower and higher molecular weight products. Suppression of MMP14 in primary osteoblasts increased membrane-bound RANKL and promoted osteoclastogenesis in cocultures with macrophages. Soluble RANKL produced by osteoblasts from MMP14-deficient mice was markedly reduced, and their osteoclastogenic activity was promoted, consistent with the findings of increased osteoclastogenesis in vivo. RANKL shedding is an important process that down-regulates local osteoclastogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m606656200

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J. P., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,534
Self-citation
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,507

Flagged first, then by citations

Show all 41 references

1 of the 41 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 237

Molecular Mechanisms Leading from Periodontal Disease to Cancer
Sobocki, B. K., Basset, C. A., Bruhn-Olszewska, B., Olszewski, P., Szot, O., Kaźmierczak-Siedlecka, K., Guziak, M., Nibali, L., & Leone, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020970 · Cited by 42
Adenovirus‐mediated expression of TIMP‐1 and TIMP‐2 in bone inhibits osteolytic degradation by human prostate cancer
Deng, X., He, G., Levine, A. L., Cao, Y., & Mullins, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23053 · Cited by 40
Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone
Govindarajan, P., Khassawna, T. E., Kampschulte, M., Böcker, W., Hürter, B., Dürselen, L., Faulenbach, M., & Heiß, C. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12038 · Cited by 38
Palmitoyl Acyltransferase, Zdhhc13, Facilitates Bone Mass Acquisition by Regulating Postnatal Epiphyseal Development and Endochondral Ossification: A Mouse Model
Song, I.-W., Li, W.-R., Chen, L., Shen, L.-F., Liu, K.-M., Yen, J. J. Y., Chen, Y., Chen, Y., Kraus, V. B., Wu, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092194 · Cited by 36
Vps33a Mediates RANKL Storage in Secretory Lysosomes in Osteoblastic Cells
Kariya, Y., Honma, M., Aoki, S., Chiba, A., & Suzuki, H. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090409 · Cited by 36
Myeloid CD34+CD13+ Precursor Cells Transdifferentiate into Chondrocyte-Like Cells in Atherosclerotic Intimal Calcification
Doehring, L. C., Heeger, C.-H. H., Aherrahrou, Z., Kaczmarek, P. M., Erdmann, J., Schunkert, H., & Ehlers, E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090758 · Cited by 34
Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males
Findlay, D. M., Chehade, M. J., Tsangari, H., Neale, S. D., Hay, S. J., Hopwood, B., Pannach, S., O’Loughlin, P. D., & Fazzalari, N. L. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2348 · Cited by 33
Supraphysiological loading induces osteocyte‐mediated osteoclastogenesis in a novel in vitro model for bone implant loosening
Fahlgren, A., Bratengeier, C., Semeins, C. M., Klein‐Nulend, J., & Bakker, A. D. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23780 · Cited by 32
Cytokines and Bone: Osteoimmunology
Lorenzo, J. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2019_346 · Cited by 32
A Functional Role for ADAM10 in Human Immunodeficiency Virus Type-1 Replication
Friedrich, B. M., Murray, J. L., Li, G., Sheng, J., Hodge, T. W., Rubin, D. H., O’Brien, W. A., & Ferguson, M. R. (2011) · Retrovirology · doi:10.1186/1742-4690-8-32 · Cited by 31
Functional analysis of a hypomorphic allele shows that MMP14 catalytic activity is the prime determinant of the Winchester syndrome phenotype
de Vos, I. J. H. M., Tao, E. Y., Ong, S. L. M., Goggi, J., Scerri, T. S., Wilson, G. R. A., Low, C. G. M., Wong, A. S. W., Grussu, D., Stegmann, A. P. A., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy168 · Cited by 30
ADAM Metalloproteinases as Potential Drug Targets
Camodeca, C., Cuffaro, D., Nuti, E., & Rossello, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180326164104 · Cited by 30
Modulation of Immune Responses by Platelet-Derived ADAM10
Maurer, S., Kopp, H., Salih, H. R., & Kropp, K. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00044 · Cited by 29
Role of RANKL in cancer development and metastasis
Okamoto, K. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01182-2 · Cited by 29
The pathophysiology of immunoporosis: innovative therapeutic targets
Ferbebouh, M., Vallières, F., Benderdour, M., & Fernandes, J. (2021) · Inflammation Research · doi:10.1007/s00011-021-01484-9 · Cited by 31
Intracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis
Stupphann, D., Rauner, M., Krenbek, D., Patsch, J., Pirker, T., Muschitz, C., Resch, H., & Pietschmann, P. (2008) · Rheumatology International · doi:10.1007/s00296-008-0567-y · Cited by 29
Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass
Nozawa, S., Inubushi, T., Irie, F., Takigami, I., Matsumoto, K., Shimizu, K., Akiyama, H., & Yamaguchi, Y. (2018) · JCI Insight · doi:10.1172/jci.insight.89624 · Cited by 28
Bone Matrix, Cellularity, and Structural Changes in a Rat Model with High-Turnover Osteoporosis Induced by Combined Ovariectomy and a Multiple-Deficient Diet
Govindarajan, P., Böcker, W., Khassawna, T. E., Kampschulte, M., Schlewitz, G., Hürter, B., Sommer, U., Dürselen, L., Ignatius, A. A., Bauer, N. B., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.011 · Cited by 28
IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice
Singh, K., Piprode, V., Mhaske, S. T., Barhanpurkar, A. P., & Wani, M. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601528 · Cited by 28
Bone sialoprotein promotes lung cancer osteolytic bone metastasis via MMP14-dependent mechanisms
Chen, W.-C., Chang, A., Tsai, H., Liu, P., Huang, C., Guo, J., Liu, C., Liu, J., Thuong, L. H. H., & Tang, C. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115540 · Cited by 28
SheddomeDB: the ectodomain shedding database for membrane-bound shed markers
Tien, W.-S., Chen, J., & Wu, K. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1465-7 · Cited by 31
Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency
Schiltz, C., Marty, C., de Vernejoul, M. C., & Geoffroy, V. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21747 · Cited by 28
Assembling the Puzzle Pieces. Insights for in Vitro Bone Remodeling
Krasnova, O. A., & Neganova, I. E. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10558-6 · Cited by 26
Fell‐Muir Lecture: Metalloproteinases: from demolition squad to master regulators
Murphy, G. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00736.x · Cited by 26
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation
Cappariello, A., Paone, R., Maurizi, A., Capulli, M., Rucci, N., Muraca, M., & Teti, A. M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.033 · Cited by 27
Effect of cyclic mechanical loading on osteoclast recruitment in periodontal tissue
Nozaki, K., Kaku, M., Yamashita, Y., Yamauchi, M., & Miura, H. (2009) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01193.x · Cited by 25
Multicentric osteolytic syndromes represent a phenotypic spectrum defined by defective collagen remodeling
de Vos, I. J. H. M., Wong, A. S. W., Welting, T. J. M., Coull, B. J., & Steensel, M. A. M. V. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61264 · Cited by 24
Targeting the receptor activator of nuclear factor‐κB (RANK) ligand in prostate cancer bone metastases
Fred Saad, C., Markus, R. A., & Goessl, C. D. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07364.x · Cited by 25
Bone Development and Remodeling
Maes, C., & Kronenberg, H. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00060-3 · Cited by 26
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis
Dovio, A., Generali, D., Tampellini, M., Berruti, A., Tedoldi, S., TORTA, M., Bonardi, S., Tucci, M., Allevi, G., Aguggini, S., et al. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0423-z · Cited by 24
Meprin and ADAM proteases as triggers of systemic inflammation in sepsis
Rahn, S., & Becker‐Pauly, C. (2021) · FEBS Letters · doi:10.1002/1873-3468.14225 · Cited by 28
Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo
Zhong, J., Wang, Z., Yuan, W., Shen, Y., & Chen, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108631 · Cited by 24
MMP14 cleaves PTH1R in the chondrocyte-derived osteoblast lineage, curbing signaling intensity for proper bone anabolism
Chu, T. L., Chen, P., Yu, A. X., Kong, M., Tan, Z., Tsang, K. Y., Zhou, Z., & Cheah, K. S. E. (2023) · eLife · doi:10.7554/elife.82142 · Cited by 20
Estrogens and androgens inhibit association of RANKL with the pre‐osteoblast membrane through post‐translational mechanisms
Martin, A., Yu, J., Xiong, J., Khalid, A. B., Katzenellenbogen, B. S., Kim, S. H., Katzenellenbogen, J. A., Malaivijitnond, S., Gabet, Y., Krum, S. A., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25862 · Cited by 24
Mechanisms of RANKL delivery to the osteoclast precursor cell surface
Honma, M., Ikebuchi, Y., & Suzuki, H. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01157-3 · Cited by 23
Global Age-Dependent Differences in Gene Expression in Response to Calvarial Injury
Wan, D. C., Kwan, M. D., Gupta, D. M., Wang, Z., Slater, B. J., Panetta, N. J., Morrell, N. T., & Longaker, M. T. (2008) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e3181843609 · Cited by 23
MT1‐MMP and ADAM10 /17 exhibit a remarkable overlap of shedding properties
Werny, L., Grogro, A., Bickenbach, K., Bülck, C., Armbrust, F., Koudelka, T., Pathak, K., Scharfenberg, F., Sammel, M., Sheikhouny, F., et al. (2022) · FEBS Journal · doi:10.1111/febs.16586 · Cited by 27
A DNA Segment Spanning the Mouse Tnfsf11 Transcription Unit and Its Upstream Regulatory Domain Rescues the Pleiotropic Biologic Phenotype of the RANKL Null Mouse
Onal, M., Bishop, K. A., John, H. C. S., Danielson, A. L., Riley, E. M., Piemontese, M., Xiong, J., Goellner, J. J., O’Brien, C. A., & Pike, J. W. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2417 · Cited by 21
Receptor Activator of NF-κB (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 Macrophages
Hakozaki, A., Yoda, M., Tohmonda, T., Furukawa, M., Hikata, T., Uchikawa, S., Takaishi, H., Matsumoto, M., Chiba, K., Horiuchi, K., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901188 · Cited by 22
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy
Timotheadou, E. T., Kalogeras, K. T., Koliou, G.-A., Wirtz, R. M., Zagouri, F., Koutras, A. K., Veltrup, E., Christodoulou, C., Pentheroudakis, G. E., Tsiftsoglou, A. P., et al. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.05.006 · Cited by 21
The effect of mechanical vibration on orthodontically induced root resorption
Yadav, S., Dobie, T., Assefnia, A., Kalajzić, Ž., & Nanda, R. (2016) · The Angle Orthodontist · doi:10.2319/090615-599.1 · Cited by 20
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
Hua, J. (2025) · Cancer Management and Research · doi:10.2147/cmar.s495169 · Cited by 21
Parathyroid hormone induces expression and proteolytic processing of Rankl in primary murine osteoblasts
Heckt, T., Keller, J., Peters, S., Streichert, T., Chalaris, A., Rose‐John, S., Mell, B., Joe, B., Amling, M., & Schinke, T. (2016) · Bone · doi:10.1016/j.bone.2016.08.016 · Cited by 19
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency
Thouverey, C., & Caverzasio, J. (2015) · Endocrinology · doi:10.1210/en.2015-1669 · Cited by 19
Unraveling the Intricacies of OPG/RANKL/RANK Biology and Its Implications in Neurological Disorders—A Comprehensive Literature Review
Freeman, C., S, M. D. A., & Priscilla, A. S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04227-z · Cited by 20
The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells
Lorenzo, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00009-8 · Cited by 20
Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis
Kodrič, K., Zupan, J., Kranjc, T., Komadina, R., Mlakar, V., Marc, J., & Lovšin, N. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0294-3 · Cited by 19
Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice
Nara, Y., Kitaura, H., Ogawa, S., Shen, W.-R., Qi, J., Ohori, F., Noguchi, T., Marahleh, A., Pramusita, A., Kinjo, R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176120 · Cited by 18
Role of RANKL Signaling in Bone Homeostasis
Sobacchi, C., Menale, C., Crisafulli, L., & Ficara, F. (2024) · Physiology · doi:10.1152/physiol.00031.2024 · Cited by 18
Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.
Kelesidis, T., Currier, J. S., Yang, O. O., & Brown, T. T. (2014) · PubMed · Cited by 17
Expression of the ectodomain‐releasing protease ADAM17 is directly regulated by the osteosarcoma and bone‐related transcription factor RUNX2
Araya, H., Sepúlveda, H., Lizama, C. O., Vega, O. A., Jerez, S., Briceño, P., Thaler, R., Riester, S. M., Antonelli, M., Salazar‐Onfray, F., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26832 · Cited by 17
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs
Aisa, M. C., Datti, A., Orlacchio, A., & Renzo, G. C. D. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.011 · Cited by 17
Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D 3 and parathyroid hormone‐induced osteoclastogenesis
Conaway, H. H., Henning, P., Lie, A., Tuckermann, J. P., & Lerner, U. H. (2019) · The FASEB Journal · doi:10.1096/fj.201802729rrr · Cited by 17
In human basophils, IL-3 selectively induces RANKL expression that is modulated by IgER-dependent and IgER-independent stimuli
Huber, C., Odermatt, A., Hagmann, B., Dahinden, C. A., & Fux, M. (2014) · Allergy · doi:10.1111/all.12497 · Cited by 17
Ectodomain Shedding of Receptor Activator of NF-κB Ligand
Hikita, A., & Tanaka, S. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_2 · Cited by 16
Self-citation
Variations in Circulating Osteoprotegerin and Soluble RANKL during Diurnal and Menstrual Cycles in Young Women
Shimizu, M., Onoe, Y., 三雲, 美., Miyabara, Y., Kuroda, T., Yoshikata, R., Ishitani, K., Okano, H., & Ohta, H. (2009) · Hormone Research in Paediatrics · doi:10.1159/000208802 · Cited by 17
Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index
Rinotas, V. E., Papakyriakou, A., Violitzi, F., Papaneophytou, C. P., Ouzouni, M., Alexiou, P., Strongilos, A. T., Couladouros, E. A., Kontopidis, G. A., Eliopoulos, E., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01316 · Cited by 16
The Role of Membrane-Type 1 Matrix Metalloproteinase–Substrate Interactions in Pathogenesis
Lee, H., Ibrahimi, L., Azar, D. T., & Han, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032183 · Cited by 17
ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
Maas, S. L., Donners, M. M. P. C., & van der Vorst, E. P. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087309 · Cited by 15
Genome-wide microarray analysis of MG-63 osteoblastic cells exposed to ultrasound
Leskinen, J. J., Karjalainen, H. M., Olkku, A., Hynynen, K., Mahonen, A., & Lammi, M. J. (2008) · Biorheology · doi:10.3233/bir-2008-0480 · Cited by 15
Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation
Patnaik, R., Riaz, S., Sivani, B. M., Faisal, S., Naidoo, N. S., Rizzo, M., & Banerjee, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290739 · Cited by 17
Systems Genetics: A Novel Approach to Dissect the Genetic Basis of Osteoporosis
Farber, C. R. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0112-5 · Cited by 14
Glucocorticoid Receptor Regulates TNFSF11 Transcription by Binding to Glucocorticoid Responsive Element in TNFSF11 Proximal Promoter Region
Lovšin, N., & Marc, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031054 · Cited by 16
Regulation of adult hematopoiesis by the a disintegrin and metalloproteinase 10 (ADAM10)
Weber, S., Wetzel, S., Prox, J., Lehmann, T., Schneppenheim, J., Donners, M. M. P. C., & Säftig, P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.020 · Cited by 14
Aminothiazoles inhibit osteoclastogenesis and PGE 2 production in LPS ‐stimulated co‐cultures of periodontal ligament and RAW 264.7 cells, and RANKL ‐mediated osteoclastogenesis and bone resorption in PBMC s
Kats, A., Gerasimčik, N., Näreoja, T., Nederberg, J., Grenlöv, S., Lagnöhed, E., Desai, S., Andersson, G., & Yucel‐Lindberg, T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14015 · Cited by 12
In vitro expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in cultured equine articular cells
Byron, C. R., Barger, A. M., Stewart, A. A., Pondenis, H. C., & Fan, T. M. (2010) · American Journal of Veterinary Research · doi:10.2460/ajvr.71.6.615 · Cited by 12
Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation
Babendreyer, A., Kieselhorst, J., Rinkens, C., Lyashenko, A. M., Düsterhöft, S., Jahr, H., Craveiro, R. B., Wolf, M., & Ludwig, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01690-y · Cited by 11
The many roles of RANKL-RANK signaling in bone, breast and cancer
Schramek, D., & Penninger, J. M. (2011) · IBMS BoneKEy · doi:10.1138/20110512 · Cited by 11
MT1-MMP
Gonzalo, P., & Arroyo, A. G. (2010) · Communicative & Integrative Biology · doi:10.4161/cib.3.3.11456 · Cited by 11
Early estrogen‐induced gene 1 facilitates osteoclast formation through the inhibition of interferon regulatory factor 8 expression
Jeong, E., Kim, J., Go, M., & Lee, S. Y. (2020) · The FASEB Journal · doi:10.1096/fj.202001197r · Cited by 7
Bone metabolism and the receptor activator of nuclear factor-κB ligand (RANKL) pathway: a comprehensive review
Peake, C. M., Shah, K., & Solan, M. C. (2021) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2021.07.006 · Cited by 9
Origins of Osteoclasts
Galson, D. L., & Roodman, G. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10002-0 · Cited by 9
Genetic Effects of Trabecular Titanium on MG-63 Cell Line: A Genetic Profiling Evaluation
Sollazzo, V., Leo, M., Pezzetti, F., Girardi, A., Farinella, F., Lorusso, V., Burelli, S., Rudolf, B. H., & Carinci, F. (2011) · ISRN Materials Science · doi:10.5402/2011/392763 · Cited by 8
Explaining RANKL inhibition by OPG through quantum biochemistry computations and insights into peptide-design for the treatment of osteoporosis
de Sousa, B. L., Barroso-Neto, I. L., Oliveira, E. F., Fonseca, E. A., de Lima‐Neto, P., Ladeira, L. O., & Freire, V. N. (2016) · RSC Advances · doi:10.1039/c6ra16712h · Cited by 8
Osteoclast Generation
Takahashi, N., Udagawa, N., Kobayashi, Y., Takami, M., Martin, T. J., & Suda, T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00029-x · Cited by 8
The relation between the RANKL and resistin in menopausal women with osteoporosis
Al-Masaoodi, R. A., AL-Sallami, A. S. M., & Al-Baseesee, H. H. (2019) · AIP conference proceedings · doi:10.1063/1.5123113 · Cited by 7
Aspects of intercellular communication in bone and implications in therapy
Martin, T. J. (2021) · Bone · doi:10.1016/j.bone.2021.116148 · Cited by 6
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course
Clar, K. L., Weber, L. M., Schmied, B. J., Heitmann, J. S., Marconato, M., Tandler, C., Schneider, P., & Salih, H. R. (2021) · Cancers · doi:10.3390/cancers13236122 · Cited by 6
Structural insights into the binding of zoledronic acid with RANKL via computational simulations
Wang, R., Zhang, W., Ma, H., Zou, D., Zhang, Z., & Wang, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.992473 · Cited by 6
Clinical and Biochemical Effects of Smoking on Non-Surgical Periodontal Treatment in Grade III Stage C Periodontitis Patients
Arikan, V., Görgülü, N. G., & Doğan, B. (2023) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1128101 · Cited by 6
Bone Deleterious Effects of Different NRTIs in Treatment-naïve HIV Patients After 12 and 48 Weeks of Treatment
Atencio, P., Conesa‐Buendía, F. M., Cabello, A., Llamas‐Granda, P., Pérez‐Tanoira, R., Prieto-Pérez, L., Álvarez, B., Acosta, I. C., Arboiro-Pinel, R., Díaz Curiel, M., et al. (2021) · Current HIV Research · doi:10.2174/1570162x19666210805094434 · Cited by 5
A Low-Phenylalanine-Containing Whey Protein Hydrolysate Stimulates Osteogenic Activity through the Activation of p38/Runx2 Signaling in Osteoblast Cells
Bu, T., Ren, Y., Yu, S., Zheng, J., Liu, L., Sun, P., Wu, J., & Yang, K. (2022) · Nutrients · doi:10.3390/nu14153135 · Cited by 5
Membrane-bound or soluble, mesenchymal or myeloid: which RANKL drives osteoclastogenesis?
Zhang, T., Feng, Y., Wang, W., Wang, W., Shan, L., Yang, X., Sun, H., & Feng, S. (2026) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2025.146 · Cited by 4
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
Vallone, V. B. F., Borzone, F. R., Martinez, L. M., Giorello, M. B., Choi, H., Dimase, F., Feldman, L. J., Bordenave, R. H., Chudzinski‐Tavassi, A. M., Batagelj, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1073793 · Cited by 5
A disintegrin and metalloproteinases (ADAMs) and tumor necrosis factor-alpha-converting enzyme (TACE)
Cuffaro, D., Scilabra, S. D., Spanò, D. P., Calligaris, M., Nuti, E., & Rossello, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00016-4 · Cited by 6
Receptors Implicated in Microgravity-Induced Bone Loss
Martinez, E. F., Pelegrine, A. A., & Holliday, L. S. (2024) · Receptors · doi:10.3390/receptors3020014 · Cited by 4
Is RANKL shedding involved in immune cell-mediated osteoclastogenesis?
Kanzaki, H., Han, X., Lin, X., Kawai, T., & Taubman, M. A. (2010) · Springer eBooks · doi:10.1007/978-4-431-99644-6_115 · Cited by 4
The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells
Lorenzo, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10007-x · Cited by 4
Basic Principles of Bone Cell Biology
Martin, T. J., Ng, K. W., & Sims, N. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00002-6 · Cited by 4
Overview of Periodontal Disease in Dogs and Cats
Hendy, E., Behery, A., Gomaa, M., Raouf, M. A. E., & Ezzeldein, S. (2026) · Journal of Veterinary Dentistry · doi:10.1177/08987564261424349 · Cited by 3
Osteoimmunology
Okamoto, K., & Takayanagi, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00016-2 · Cited by 3
Cytokines and the Pathogenesis of Osteoporosis
Lorenzo, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00038-8 · Cited by 3
RANKL and periodontitis
Ando, Y., & Tsukasaki, M. (2023) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22122 · Cited by 2
Peonidin-3-O-glucoside and Resveratrol Increase the Viability of Cultured Human hFOB Osteoblasts and Alter the Expression of Genes Associated with Apoptosis, Osteoblast Differentiation and Osteoclastogenesis
Mendoza, K. C. O., Buenrostro, K. D. G., Kanabar, P. N., Maienschein‐Cline, M., Los, N. S., Arbieva, Z. H., Raut, N. A., Lawal, T. O., López, A. M., Cabada-Aguirre, P., et al. (2023) · Nutrients · doi:10.3390/nu15143233 · Cited by 3
Osteoclastogenesis and vitamin D
Nakamichi, Y., Takahashi, N., Suda, T., & Udagawa, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00021-0 · Cited by 2
Staphylococcus Infection Associated with Arthroplasty
Ye, W., Shang, W., & Yang, Y. (2012) · InTech eBooks · doi:10.5772/25783 · Cited by 2
Inhibition of membrane RANKL production in osteoblasts mediates curcumin-inhibited osteoclastogenesis
Gao, T., Ke, T., 肖展豪, & Gao, X. (2026) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2026e15332 · Cited by 1
New insights into osteocyte and osteoblast biology: support of osteoclast formation, PTH action and the role of Wnt16 (ASBMR 2013)
Sims, N. A. (2013) · IBMS BoneKEy · doi:10.1038/bonekey.2013.201 · Cited by 1
A view at monoclonal antibodies in therapy of osteoporosis
Michałowska, M., Znorko, B., Oksztulska-Kolanek, E., Kaminski, T. W., & Pawlak, D. (2015) · Polish Annals of Medicine · doi:10.1016/j.poamed.2015.07.002 · Cited by 1
The Variety of Osteocyte Function
O’Brien, C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00006-2 · Cited by 1

Authors: Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S.
Affiliations: The University of Tokyo (JP)
Institute of Medical Science, The University of Tokyo (JP)
Corresponding author: Tanaka, Sakae
ORCID: Hikita, Atsuhiko
Nakamura, Masaki
Kadono, Yuho
Oshima, Yasushi
Seiki, Motoharu
Tanaka, Sakae
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2006-12
Volume: 281
Issue: 48
Pages: 36846-36855
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m606656200
OpenAlex: W1999201913
Cited by: 236
References: 41
Citations by year: 2026: 6 · 2025: 4 · 2024: 8 · 2023: 15 · 2022: 7 · 2021: 13 · 2020: 15 · 2019: 8 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 10 · 2014: 9 · 2013: 8 · 2012: 12
FWCI: 6.66
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 5056 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords: RANKL, ectodomain shedding, osteoclastogenesis, MMP-14, ADAM10, soluble RANKL, osteoblasts
MeSH terms: ADAM10 Protein, Animals, Binding Sites, Bone Diseases, Metabolic, Bone Marrow, Humans, Macrophages, Membrane Proteins, Mice, Inbred C57BL, Osteoblasts, Osteoclasts, Down-Regulation, Coculture Techniques, Mice, ADAM Proteins, RANK Ligand, Matrix Metalloproteinase 14, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks